Earum Pharmaceuticals IPO description – Earum Pharmaceuticals is engaged in the pharmaceutical business involving marketing, trading and distribution of wide range of pharmaceutical formulation products such as anti-biotic drugs, anti-malarial drugs, anti-allergic & anti cold drugs, analgesic/ anti-pyretic & anti inflammatory drugs, dermatology products, cerebral activator drugs, neurological drugs, gastro intestinal drugs, steroids, gynecology drugs, calcium, multivitamins, anti-oxidants and injections. As on date of Prospectus, the company offered around 125 pharmaceutical formulation products, of which around 24 products are marketed under its own brand name with manufacturing outsourced to third parties.
Apart from pharmaceutical formulation products, the company also deals in trading of active pharmaceutical ingredients (API’s) such as Levofloxacin Hemihdrate IP Albendazol IP, Amoxicillin Trihydrate IP etc.
Earum Pharmaceuticals promoters – Mr Bhumishth Narendrabhai Patel and Mrs Payal Bhumishth Patel
| Earum Pharmaceuticals – Upcoming IPO details | |
| Subscription Dates | 21 – 26 June 2019 |
| IPO Price band | INR36 per share |
| Fresh issue | 1,848,000 shares (INR6.65 crore) |
| Offer for sale | Nil |
| Total IPO size | 1,848,000 shares (INR6.65 crore) |
| Minimum bid (lot size) | 3,000 shares |
| Face Value | INR10 per share |
| Retail Allocation | 50% |
| Listing On | BSE SME platform |
Use of funds
- Working capital requirements – INR5.00 crore
- General corporate purposes – INR0.86 crore
- Issue Expenses – INR0.79 crore
| Earum Pharmaceuticals’ standalone financial performance (in INR crore) | ||||||
| FY2016 | FY2017 | FY2018 | 9M FY2019 | |||
| Total revenue | 18.63 | 23.69 | 35.85 | 34.50 | ||
| Total expenses | 18.47 | 23.46 | 34.61 | 33.31 | ||
| Profit after tax | 0.10 | 0.16 | 0.86 | 0.87 | ||
Earum Pharmaceuticals Contact Details
Earum Pharmaceuticals LimitedÂA-1106, Empire Business Hub
Nr. AUDA Water Tank, Science City Road, Sola
Ahmedabad 380060 Phone:Â +91 79 48402525
Email: [email protected]
Website:Â www.earumpharma.com
Earum Pharmaceuticals IPO Subscription Details
| Day | Subscription (no. of times) |
| Day 1 | 0.55 |
| Day 2 | 0.73 |
| Day 3 | 1.01 |
| Day 4 | 1.51 |
Earum Pharmaceuticals Valuation (For FY2018)
Earnings Per Share (EPS): INR3.50
Price/Earnings (P/E) ratio: 10.29
Return on Net Worth (RONW): 20.34%
Net Asset Value (NAV): INR136.46 per share
Registrar of Earum Pharmaceuticals IPO
Bigshare Services Private LimitedÂE2, Ansa Industrial Estate, Sakivihar Road,
Sakinaka, Andheri (E)
Mumbai – 400 072 Phone: +91 22 4043 0200Â
Fax:Â +91 22Â 2847Â 5201
Email:Â [email protected]
Website:Â www.bigshareonline.com
Earum Pharmaceuticals IPO Allotment Status
Earum Pharmaceuticals IPO allotment status is now available on Bigshare Services’ website. Click on this link to get allotment status.
Listing performance of Earum Pharmaceuticals
IPO Opening Date: 21 June 2019
IPO Closing Date: 26 June 2019
Listing Date: 4 July 2019
Listing Price on BSE SME: INR36 per share (no change from IPO price)
Closing Price on BSE SME: INR36.05 per share (up 0.14% from IPO price)
Â
Read Also: Parshva Enterpises IPO Details
